- Home
- TNGX vs URG Comparison
TNGX vs URG Comparison
Compare TNGX & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- URG
- Stock Information
- Founded
- TNGX 2014
- URG 2004
- Country
- TNGX United States
- URG United States
- Employees
- TNGX N/A
- URG N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- URG Precious Metals
- Sector
- TNGX Health Care
- URG Basic Materials
- Exchange
- TNGX Nasdaq
- URG Nasdaq
- Market Cap
- TNGX 317.4M
- URG 326.6M
- IPO Year
- TNGX N/A
- URG N/A
- Fundamental
- Price
- TNGX $1.37
- URG $0.66
- Analyst Decision
- TNGX Strong Buy
- URG Strong Buy
- Analyst Count
- TNGX 7
- URG 2
- Target Price
- TNGX $12.33
- URG $2.45
- AVG Volume (30 Days)
- TNGX 789.1K
- URG 5.4M
- Earning Date
- TNGX 05-07-2025
- URG 05-05-2025
- Dividend Yield
- TNGX N/A
- URG N/A
- EPS Growth
- TNGX N/A
- URG N/A
- EPS
- TNGX N/A
- URG N/A
- Revenue
- TNGX $42,069,000.00
- URG $16,494,000.00
- Revenue This Year
- TNGX N/A
- URG $86.92
- Revenue Next Year
- TNGX N/A
- URG $36.42
- P/E Ratio
- TNGX N/A
- URG N/A
- Revenue Growth
- TNGX 15.17
- URG 34.78
- 52 Week Low
- TNGX $1.33
- URG $0.63
- 52 Week High
- TNGX $12.02
- URG $1.90
- Technical
- Relative Strength Index (RSI)
- TNGX 26.22
- URG 30.48
- Support Level
- TNGX $1.48
- URG $0.78
- Resistance Level
- TNGX $1.66
- URG $0.95
- Average True Range (ATR)
- TNGX 0.16
- URG 0.06
- MACD
- TNGX -0.01
- URG -0.01
- Stochastic Oscillator
- TNGX 5.63
- URG 4.28
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.